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Abstract
Opening of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels is facilitated by direct binding of cyclic
nucleotides to a cyclic nucleotide-binding domain (CNBD) in the C-terminus. Here, we show for the first time that in the
HCN2 channel cGMP can also exert an inhibitory effect on gating via cGMP-dependent protein kinase II (cGKII)-mediated
phosphorylation. Using coimmunoprecipitation and immunohistochemistry we demonstrate that cGKII and HCN2 interact
and colocalize with each other upon heterologous expression as well as in native mouse brain. We identify the proximal C-
terminus of HCN2 as binding region of cGKII and show that cGKII phosphorylates HCN2 at a specific serine residue (S641) in
the C-terminal end of the CNBD. The cGKII shifts the voltage-dependence of HCN2 activation to 2–5 mV more negative
voltages and, hence, counteracts the stimulatory effect of cGMP on gating. The inhibitory cGMP effect can be either
abolished by mutation of the phosphorylation site in HCN2 or by impairing the catalytic domain of cGKII. By contrast, the
inhibitory effect is preserved in a HCN2 mutant carrying a CNBD deficient for cGMP binding. Our data suggest that
bidirectional regulation of HCN2 gating by cGMP contributes to cellular fine-tuning of HCN channel activity.
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Introduction
Hyperpolarization-activated cyclic nucleotide-gated channels
(HCN1-4) comprise an ion channel family of four distinct
members that pass a current termed Ih or If [1,2,3,4]. Ih is widely
found in nervous system and heart and has been known to play a
key role in controlling cardiac and neuronal rhythmicity
(‘‘pacemaker current’’) [4,5]. Besides its pacemaker function, Ih
contributes to other basic neuronal processes, including determi-
nation of resting membrane potential [6,7,8], dendritic integration
[9,10] and synaptic transmission [11]. Impaired function of HCN
channels has been implicated in the pathologies of epilepsies,
neuropathic pain disorders, and cardiac arrhythmia [2,3].
Structurally, HCN channels belong to the 6 transmembrane ion
channel superfamily. HCN channels are set apart from other
members of this family by their unusual activation process that
includes principal gating by membrane hyperpolarization (con-
ferred by a transmembrane voltage sensor) and modulation of the
voltage-dependence of activation by binding of cyclic nucleotides
to the C-terminal cyclic nucleotide-binding domain (CNBD). The
latter process is of crucial relevance because it connects HCN
channel activation to numerous signal transduction pathways that
control cellular levels of cAMP or cGMP.
There is recent evidence that HCN channel activity is also subject
to regulation by protein kinases. For example, in hippocampal
pyramidal neurons, the activation of p38 MAPKshifts the activation
curve of Ih towards more positive potentials [12]. There are also
some reports on protein kinase A-mediated phosphorylation of
HCN channels [13,14,15]. Recently, the Src tyrosine kinase has
been identified as another modulator of HCN channel gating [16].
Given these findings, we were wondering whether HCN
channels may be regulated by additional, not yet specified
proteins, and in particular by protein kinases. We focused our
study on the HCN2 channel isoform because this channel is the
most widely expressed HCN channel type in brain and heart
[17,18]. We provide evidence for the functional interaction
between HCN2 and the cGMP-dependent protein kinase II
(cGKII). Importantly, we demonstrate that cGKII-mediated
phosphorylation of HCN2 shifts the voltage-dependence of
channel activation to more negative voltages and, hence,
counteracts the stimulatory action of cyclic nucleotides conferred
by the CNBD. We propose that bidirectional regulation of HCN
channel activation by cyclic nucleotides plays an important role in
regulating the set point and threshold of HCN channel activation
in neurons.
Results
The HCN2 channel interacts with cGKII via its proximal C-
terminus
In a screen to identify protein kinases interacting with HCN
channels, we coexpressed HCN2 and cGKII in HEK293 cells.
Upon coimmunoprecipitation (Co-IP) with an anti-cGKII anti-
body, a 100 kDa band corresponding to HCN2 was detected in
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17078immunoblots (Fig. 1A). To verify a specific interaction of the two
proteins we performed Co-IP experiments with anti-cGKII
antibody in lysates from mouse hypothalamus, a brain region
known to express both HCN2 and cGKII [19,20]. Again, a
specific HCN2 band was detected (Fig. 1B, left lane) confirming an
in vivo interaction of HCN2 and cGKII. Importantly, the HCN2
band was not present in hypothalamic tissue from HCN2-deficient
mice (Fig. 1B, right lane).
To further narrow down the region of HCN2 that interacts with
cGKII, Co-IPs with GFP-tagged cGKII and myc-proteins
corresponding to the combined C-linker/cyclic-nucleotide binding
domain (L+CNBD, aa 443–647), the C-linker (L, aa 443–525) or
the distal C-terminus of the HCN2 channel (dC, aa 647–863) were
performed (Fig. 1C, D). Distinct bands were obtained for the
combined C-linker/CNBD region (Fig. 1D, left lane) while no
interaction was found for the C-linker alone (Fig. 1D, middle lane)
as well as for the sequence downstream of the cyclic-nucleotide
binding domain region (Fig. 1D, right lane). Together, these
findings indicated that the CNBD is required for the interaction
with cGKII, either alone or in conjunction with the C-linker.
Attempts to perform Co-IPs with the isolated CNBD failed
because of problems with protein stability (data not shown).
HCN2 and cGKII are coexpressed in mouse brain
In order to study the subcellular localization of cGKII and
HCN2, primary hippocampal neurons were cotransduced with
Figure 1. Interaction between HCN2 and cGKII. (A) Coimmunoprecipitation of HCN2 and cGKII in HEK293 cells. Lysates of HEK293 cells
transfected with HCN2 and cGKII or cGKII alone were immunoprecipitated (IP) using a cGKII antibody and stained for HCN2 and cGKII as loading
control. 500 mg protein was applied per lane. (B) Protein extracts of hypothalamic brain tissue from WT and HCN2-KO mice were immunoprecipitated
using a cGKII antibody and analyzed in immunoblots (IB) for HCN2. Anti-cGKII served as loading control. (C) Schematic representation of full length
HCN2 (862 amino acids) and myc-tagged HCN2-domains used for interaction studies. The calculated molecular size of the proteins is indicated. NT, N-
terminus; TMR, transmembrane region; CT, complete HCN2 C-terminus; L, C-linker; CNBD, cyclic nucleotide-binding domain; dC, distal C-terminus. (D)
GFP-Trap. Lysates of HEK293 cells coexpressing cGKII-GFP and myc-tagged portions of the HCN2 C-terminus were bound to GFP-tagged beads. Co-
immunoprecipitated proteins were detected by immunoblotting with an anti-myc antibody. Anti-cGKII was used as loading control.
doi:10.1371/journal.pone.0017078.g001
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cGKII-myc fusion protein, respectively. Subsequent immunocy-
tochemical staining showed colocalization of the two proteins at
the plasma membrane (Fig. 2A–C). In the absence of primary
antibodies immunostaining was not observed, demonstrating the
specificity of the antibodies used (Fig. 2D). Immunohistochemistry
revealed broad expression of cGKII (Fig. 2E) and HCN2 (Fig. 2F)
in coronal sections of mouse brain. No specific staining was
observed in brain sections of mice deficient for cGKII (Fig. 2G) or
HCN2 (Fig. 2H), respectively. High levels of cGKII mRNA have
been reported to exist in thalamic and hypothalamic regions [19].
In agreement with this finding, we observed coexpression of high
levels of cGKII and HCN2 protein in consecutive slices covering
the hypothalamus (Figs. 2I and 2J).
HCN2 is phosphorylated by cGKII at position S641
We next tested whether HCN2 can be phosphorylated by
cGKII. In lysates of HEK293 cells coexpressing HCN2 and
cGKII a 100 kDa phosphorylated protein band corresponding to
HCN2 appeared after the addition of [c-
32P]-ATP. By contrast, in
lysates lacking cGKII the 100 kDa HCN2 band was not observed
(Fig. 3A). HCN2 contains three serines that are located within a
consensus site (K/R-K/R-X-S/T) for phosphorylation by cGKs
(S641, S786 and S840; Fig. 3B). Serine 641 is located at the distal
end of the a-C helix of the CNBD and is present in all four
members of the HCN channel family. By contrast, the two distal
consensus sites (S786 and S840) are not conserved throughout the
HCN channel family (HCN1 and HCN3 contain no phosphor-
ylation consensus sites at positions equivalent to S786 or S840;
HCN4 contains only the consensus site at the position equivalent
to S786). A HCN2 truncation mutant lacking the last two serines
(HCN2-756STOP) was still efficiently phosphorylated by cGKII
(Fig. 3C, left lane). By contrast, a cGKII-dependent phosphory-
lation of HCN2 was not detectable when S641 was mutated to an
alanine (S641A). In order to validate these findings, we analyzed
the binding of C-terminal HCN2 constructs (HCN2-CT and
HCN2-CT-S641A) to TiO2 beads (Fig. 3D). TiO2 efficiently binds
negatively charged peptides and hence, can be used to determine
alterations of the ratio of (highly charged) phosphorylated versus
(less charged) non-phosphorylated peptides. After precipitation by
TiO2 and subsequent western blot analysis with anti-myc
antibody, an intense 50 kDa band was detected in lysates
containing myc-tagged HCN2-CT and cGKII (Fig. 3D, second
lane). By contrast, only a weak band was obtained for HCN2-CT-
S641A (Fig. 3D, third lane). Densitometric analysis revealed that
the intensity of the HCN2-CT-S641A band was only 32.261.1%
of that of the HCN2-CT band (n=4, p,0.01). Weak bands were
also obtained for HCN2-CT and HCN2-CT-S641A when cGKII
was not present in the assay (Fig. 3D, fourth and fifth lane).
Notably, the intensity of the bands obtained in the absence of
cGKII did not differ between wild type and mutant C-termini.
Taken together, these findings indicated that the strong interaction
between HCN2-CT and the TiO2 beads was caused by cGKII-
mediated phosphorylation of S641. The weak bands seen for
HCN2-CT-S641A may reflect background phosphorylation by
endogenous kinases. Alternatively, the HCN2 C-terminus may be
acidic enough in its non-phosphorylated form to bind to some
extent to the TiO2 beads.
cGKII shifts the half maximal activation voltage of HCN2
to more negative values
We next tested whether cGKII affects the properties of HCN2-
mediated currents. To this end we transiently expressed wild type
and mutant HCN2 in HEK293 cells and determined Ih by
applying hyperpolarizing voltage steps from 2140 mV to
260 mV in 10 mV increments from a holding potential of
240 mV for followed by a step to 2140 mV (Fig. 4A). The
presence of cGKII had no influence on current densities (at
2140 mV: HCN2: 2155624.7 pA/pF, n=15; HCN2/cGKII:
2170643.4 pA/pF, n=7) nor did it influence the activation
kinetics of HCN2-mediated currents (t at 2140 mV: HCN2:
293615.2 ms, n=15; HCN2/cGKII: 309628.6 ms, n=7).
However, cGKII induced a hyperpolarizing shift of the voltage-
dependence of activation of HCN2 currents in the presence of
cGMP. At 10 mM cGMP which is close to the Ka (cGMP) of
HCN2 [20] the shift was about 24m V( V 0.5 values at 10 mM
cGMP. HCN2: 295.560.49 mV, n=16; HCN2/cGKII:
299.360.74 mV, n=13) (Fig. 4B). The hyperpolarizing shift
was somewhat smaller at 100 mM cGMP (Fig. 4C)
(DV=22.2 mV; V0.5 values at 100 mM cGMP. HCN2:
289.261.02 mV, n=8; HCN2/cGKII: 291.461.17 mV,
n=7) while it was more pronounced at a low cGMP concentration
(Fig. 4D) (DVa t1mM cGMP=24.9 mV; V0.5 values at 1 mM
cGMP. HCN2: 296.160.68 mV, n=7; HCN2/cGKII:
210160.35 mV, n=7). No shift was observed at 2 mM cAMP
(Fig. 4E). It is well known that the V0.5 value of HCN2 currents is
shifted to more positive values by direct interaction of cGMP with
the CNBD [2]. This direct cGMP-mediated voltage shift (DV0.5)
was about +7.5 mV at 10 mM cGMP (Fig. 4H, first two columns).
In the presence of cGKII the cGMP-mediated shift was reduced to
about 4 mV (Fig. 4B, and Fig. 4H, third and fourth column)
suggesting that cGKII counteracted the stimulatory effect exerted
by direct binding of cGMP to the channel CNBD.
We next asked whether phosphorylation at S641 is required for
the inhibitory effect of cGKII. In line with a crucial role of S641
for this inhibitory effect, the cGMP/cGKII-mediated hyperpolar-
izing shift of the V0.5 value was not observed in currents from
HCN2-S641A channels (V0.5 value at 10 mM cGMP:
294.660.95 mV, n=15) (Fig. 4F and Fig. 4H fourth and fifth
column). Similarly, inactivation of cGKII by either introducing a
point mutation in the catalytic domain (cGKII-D576A [21]) or by
addition of a specific pharmacological blocker KT5823 abolished
the inhibitory cGKII effect on WT HCN2 to a similar extent as
the S641A mutation (Fig. 4H, sixth and seventh column). We
finally asked whether the inhibitory effect of cGKII requires
binding of cGMP to the CNBD or whether it is independent from
the direct cGMP effect of the channel. To this end, we employed a
HCN2 mutant (HCN2-RT.EA) that carries two amino acid
replacements in the b7 strand of the CNBD (R591E and T592A)
that are known to abolish cGMP binding and the cGMP-mediated
shift of the V0.5 value of HCN2 currents to more positive values
[22]. In the presence of 10 mM cGMP and the cGKII, the V0.5 of
the HCN2-RT.EA mutant was much more negative than that of
WT HCN2 (Fig. 4G, columns four and eight. V0.5 values at
10 mM cGMP. HCN2-RT.EA: 210360.77 mV, n=16). Im-
portantly, however, introduction of the S641A mutation into the
HCN2-RT.EA backbone again eliminated the hyperpolarizing
shift by cGMP/cGKII and lead to a positive shift of the V0.5
compared to HCN2-RT.EA plus cGMP/cGKII (Fig. 4H, last
two columns; DV0.5=+3.4 mV; HCN2-RT.EA/cGKII:
2103.060.77 mV, n=16; HCN2-S641A-RT.EA/cGKII:
299.660.76 mV, n=10).
Discussion
So far, there are only a few reports on the regulation of Ih by
cGMP. Pape et al. showed that NO/cGMP controls oscillatory
activity in thalamocortical neurons via direct upregulation of Ih
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e17078[23]. In addition, cGMP-mediated activation of sinoatrial Ih may
induce an increase in heart rate [24]. In this study, we provide for
the first time evidence for a bidirectional regulation of the HCN2
channel gating by cGMP (Fig. 5). It has long been known that
cGMP, like cAMP, shifts the voltage-dependence of HCN channel
activation to more positive values and, thereby, acts as a positive
regulator of channel activity [2,4]. Mechanistically, this regulation
is conferred by direct binding of cGMP to the CNBD, which is
allosterically coupled to the HCN channel activation gate. Our
data indicate that cGMP can also act as a gating inhibitor via
cGKII-dependent phosphorylation. We show that cGKII binds to
the C-terminus of HCN2 and phosphorylates this channel at S641.
Phosphorylation of S641 shifts the midpoint potential of HCN2 by
about 4 mV to more hyperpolarizing values. The effect of cGKII
is independent of the capability of the CNBD to bind cGMP since
it also occurs in a HCN2 mutant with functionally impaired
Figure 3. Phosphorylation of HCN2 by cGKII. (A) In vitro phosphorylation of HCN2 by cGKII. Lysates of COS-7 cells expressing HCN2 and cGKII
were incubated with [c-32P]-ATP for the times indicated. After incubation, proteins were separated on SDS page and analyzed by autoradiography.
The first lane represents a control reaction with a cell lysate lacking cGKII. (B) HCN channel constructs used for phosphorylation studies. The positions
of the three putative cGKII phosphorylation sites (S641, S786 and S840) are indicated. The calculated molecular mass is given for each construct. (C)
Phosphorylation assay of a HCN2 mutant lacking S786 and S840 (first lane) and the HCN2-S641A mutant. (D) Pulldown of phosphoproteins by TiO2
beads. Lysates of cells expressing HCN2-CT or HCN2-CT-S641A in the presence or absence of cGKII, respectively, were incubated with TiO2 beads.
Proteins specifically bound to the beads were analyzed with an anti-myc antibody.
doi:10.1371/journal.pone.0017078.g003
Figure 2. Colocalization of HCN2 and cGKII in neurons. (A–D) Colocalization in primary neurons. Hippocampal neurons of neonatal mice
(E16.5) were cotransduced with lentivirus expressing HCN2 and cGKII-myc, respectively. Neurons were stained with antibodies against myc (A) and
HCN2 (B). Counterstaining was performed with Hoechst dye. (C) Merge of (A) and (B). (D) Negative control (nc). Merge of stainings in the absence of
primary antibodies. Scale bar corresponds to 100 mm. (E–H) Immunohistochemical staining of coronal brain slices. Consecutive slices from wild-type
mice were stained with anti-cGKII (E) or anti-HCN2 (F). The signal was amplified by tyramide signal amplification. Counter stain was performed with
Hoechst 33342 nuclear dye. As negative control, coronal slices of cGKII-KO (G) and HCN2-KO mice (H) were used. Scale bar corresponds to 500 mm.
(I, J) Higher magnification of cGKII (I) and HCN2 (J) staining in the hypothalamic region corresponding to the dotted white box as indicated in (E).
Scale bar corresponds to 50 mm.
doi:10.1371/journal.pone.0017078.g002
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T592A channels are not statistically different from each other (for
both V0.5 is ,2103 mV). Introduction of S641A also does not
change V0.5 with respect to WT in the absence of cGMP. Thus,
one would not expect a negative shift exerted by the kinase per se.
Indeed, our measurements demonstrate that in the absence of
cGMP V0.5 of HCN2 is not altered by cGKII (see Fig. 4H, first
and third column: V0.5 of HCN2=2103 mV; V0.5 of
HCN2+cGKII=2102 mV). By contrast, comparison of V0.5 of
the HCN2-R591E/T592A channel with that of the HCN2-
S641A/R591E/T592A triple mutant in the presence of cGMP
(which is required to activate the kinase) clearly reveals the
inhibitory effect of cGKII on HCN2 gating.
It is noteworthy to mention that the apparent cGMP affinity of
HCN2 is about 30 times lower than that reported for cGKII
(6 mM vs. 0.2 mM [20,25]). Thus, at very low cGMP concentra-
tions the inhibitory action of cGMP via cGKII may be dominant
while at higher concentrations of cGMP the direct stimulatory
effect more and more outweighs the inhibition imposed by the
kinase. This hypothesis is supported by our finding that the
hyperpolarizing shift induced by cGKII was more pronounced at
low (1 mM) than at high (100 mM) cGMP concentration. Finally,
our data indicate that low micromolar concentrations of cAMP
that activate HCN2 currents by binding to the CNBD do not
cross-stimulate cGKII and thus should not interfere with the
cGKII-dependent modulation of HCN2.
The exact mechanism underlying the cGKII-mediated inhibi-
tion of channel gating remains to be determined. S641 is localized
at the C-terminal end of the aC-helix of the CNBD, which has
been shown to play an important role in HCN channel gating
[26,27]. One may speculate that the presence of the bulky
negatively charged phosphate group could well interfere with the
allosteric movement of the proximal C-terminus of HCN2 during
channel gating. Other protein kinases, including Src kinase [16]
and protein kinase A [15] have been also shown to regulate HCN
channel gating via phosphorylation in the C-terminus. Thus,
phosphorylation is probably a common cellular mechanism to
modulate HCN channel activity.
We could provide direct experimental evidence for colocalization
of HCN2 and cGKII in mouse brain. Given the widespread
distribution of both proteins in brain [18,19,28], regulation of HCN2
by cGKII could be potentially relevant in many types of neurons.
Given that S641 is highly conserved within the HCN channel family,
this kind of regulation may be a commonality of HCN channels.
A modulatory action of cGKII on other ion channels was only
established for the cystic fibrosis transmembrane conductance
regulator (CFTR)-Cl
2 channel and the AMPA receptor subunit
GluR1. In both cases, cGKII was shown to increase the cell
surface expression [29]. CFTR was also shown to be activated by
cGMP/cGKII [30,31]. Our coexpression studies in HEK293 cells
and primary hippocampal neurons do not support an effect of
cGKII on HCN2 trafficking and cell surface expression.
In conclusion, we provide evidence that the voltage-dependence
of HCN2 activation is determined by complex interactions of
multiple signaling pathways that control the concentration of
cGMP and/or cAMP and the activity of cGKII. HCN2 is a key
determinant of resting membrane potential in neurons and plays a
key role in controlling neuronal excitability [8]. Thus, a cGKII-
mediated phosphorylation and change of the value of half-
maximal activation of HCN2 in neurons would immediately
interfere with neuronal activity because it directly affects the
threshold at which HCN2 can be activated.
It is tempting to speculate, that in addition to the well
established up-regulation of Ih by cAMP and/or cGMP, neurons
that express cGKII are also be able to down-regulate Ih via the
NO/cGMP system by changing the ratio of phosphorylated versus
non-phosphorylated HCN2 channels. This ‘‘dual modulation by
cGMP’’ may have evolved to allow a tighter control of HCN
channel activity, and thus, a better control of the threshold for
activation of neurons.
Materials and Methods
Lentiviral and expression vectors
To construct the LV-Syn1.1-eGFP lentiviral vector plasmid, we
replaced the CMV promoter sequence in LV-CMV-eGFP [32]
with a rat synapsin 1 promoter sequence, which was PCR
amplified from the FSy(1.1)GW plasmid (kindly provided by Pavel
Osten, SUNY Downstate Brooklyn) [33]. LV-Syn1.1-HCN2 was
prepared by replacing the eGFP sequence in LV-Syn1.1-eGFP
with the mouse HCN2 cDNA [20]. The coding region of the
mouse cGKII [34] was subcloned into the pcDNA3 (Invitrogen)
and pIRES-EGFP (Clonetech), respectively. LV-Syn1.1-cGKII
was prepared by replacing the eGFP sequence in LV-Syn1.1-
Figure 5. Model of the bidirectional regulation of HCN2 gating
by cGMP. cGMP shifts the voltage-dependence of HCN2 activation to
more positive voltage (+DV) via direct interaction with the CNBD of
HCN2 and induces a hyperpolarizing shift (2DV) by activating cGKII that
is bound to the channel.
doi:10.1371/journal.pone.0017078.g005
Figure 4. Regulation of voltage-dependence of HCN2 activation by cGKII. (A) Voltage step protocol and family of current traces of a HEK293
cell transiently transfected with HCN2. (B–D) Normalized current-voltage (IV) dependence of HCN2 activation in the presence and absence of cGKII.
The voltage-dependence was determined in the presence of 10 mM intracellular cGMP (B), 100 mM intracellular cGMP (C) and 1 mM intracellular cGMP
(D). (E) IV curves of HCN2 in the presence or absence of cGKII at 2 mM intracellular cAMP. (F) IV curves determined at 10 mM intracellular cGMP from
cells coexpressing cGKII and HCN2 or HCN2-S641A. (G) IV curves of HCN2 compared to the IV curve of an HCN2 mutant with functionally impaired
cyclic nucleotide binding domain (HCN2-RT.EA) that was coexpressed with cGKII. Currents were measured in the presence of 10 mM cGMP. (H)
Comparison of midpoint potentials (V0.5) of wild type (WT) and HCN2 mutants (HCN2-S641A, HCN2-RT.EA). Channels were expressed alone or
together with either wild type or catalytically inactive GKII (cGKII-D576A). V0.5 was determined from the normalized IV curves in the presence (+)o r
absence (2)o f1 0mM cGMP as indicated. In one set of experiments the cGKII was inhibited by the pharmacological blocker KT5823. ***=p,0.001.
doi:10.1371/journal.pone.0017078.g004
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High titer replication-deficient lentiviral vector particles were
generated as described previously [32]. Mutations in the HCN
channel and cGKII were introduced by site directed mutagenesis
(QuikChange II kit, Stratagene). An overview of the HCN2
channel constructs used in this study is shown schematically in
Figures 1C and 3B.
Mice
The HCN2-deficient mouse line was described previously [8] as
well as the cGKII-deficient mouse line [35]. All animals have a
mixed background of 129SvJ and C57-Bl6/N strains, received
food and water ad libitum and lived in a light-dark cycle of 12 h.
All mouse husbandry and experimental procedures were per-
formed in accordance with the German animal protection
standards and were approved by the Government of Upper
Bavaria (Regierung von Oberbayern, Munich, Germany) and the
permit number is 55.2-1-54-2531-88-05.
Cell culture
HEK293 and COS7 (DSMZ) cells were maintained in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented
with 10% fetal bovine serum (Biochrom AG), 100 units/ml
penicillin and 100 units/ml streptomycin (Biochrom AG) at 37uC
and 10% CO2. For biochemical experiments, HEK293 or COS-7
cells were transfected using the calcium phosphate method and for
electrophysiological experiments the FuGene6 transfection reagent
(Roche) was used.
Primary hippocampal neuron culture
Primary neurons of C57-Bl6/N mice were isolated as described
previously [36]. Briefly, brains of mouse embryos were dissected
on embryonic day 16.5 (E16.5) and the hippocampi were isolated.
After incubation with trypsin-EDTA, the tissue was dissociated.
Approximately 100,000 primary hippocampal neurons were
plated on acid-washed, poly-l-lysine treated coverslips. The culture
was maintained at 36.5uC and 5% CO2 in N2-medium (N-MEM
containing N2 supplement (Invitrogen) and 200 g/l ovalbumin
(Sigma)). On day two after plating, the primary neuron culture was
transduced with lentiviral particles expressing either a cGKII-myc
fusion protein or HCN2.
Immunocytochemistry
Except slight modifications, staining of primary hippocampal
neurons was performed as described previously [37]. Cells were
fixed with 4% paraformaldehyde containing 4% sucrose in
phosphate buffered saline (PBS) at room temperature for
20 min. Subsequently, cells were quenched with 50 mM ammo-
nium chloride, permeabilized with 0.1% Triton X-100 (Roth) and
blocked with 2% fetal bovine serum and 2% bovine serum
albumin containing 0.2% cold water fish gelatin. Primary neurons
were incubated over night at 4uC with anti-HCN2 (Alomone) and
anti-myc (clone 9B11, Cell Signaling) diluted in 5% Chemiblocker
(Chemicon). After excessive washing with PBS, the cells were
incubated for 1 h at room temperature with secondary antibodies,
Cy3arb and Cy2ams (Jackson) diluted in 2% Chemiblocker.
Hoechst 33342 DNA stain (Invitrogen, 5 mg/ml) was used to
visualize cell nuclei. The cells were examined on a confocal laser
scanning microscope (LSM510 Meta, Zeiss).
Immunohistochemistry
Twelve mm thick coronal cryosections of adult mouse brain
were fixed with 4% paraformaldehyde in PBS and blocked with
PBS containing 10% normal goat serum (Vector laboratories) and
0.3% Triton X-100. Anti-HCN2 (Alomone) and anti-cGKII [38]
were used as primary antibodies. Endogenous peroxidase activity
was quenched (3% H2O2 in methanol) before sections were
incubated with horseradish peroxidase-conjugated anti-rabbit IgG
antibodies (Jackson). Tyramide signal amplification was performed
according to manufacturer’s instruction using Cy3-conjucated
tyramide (TSA-Plus Cyanine 3 System, Perkin Elmer). To
visualize cell nuclei, slices were counter stained with 5 mg/ml
Hoechst 33342. The brain slices were examined on an
epifluorescence microscope (Axioplan 2, Zeiss) and a confocal
laser scanning microscope (Leica TCS LSI).
Coimmunoprecipitation
For protein analysis, transfected HEK293 cells or dissected
brains were homogenised in lysis buffer (50 mM Tris-HCl pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100) containing
proteinase inhibitors (PI) (complete, EDTA-free proteinase
inhibitor cocktail tablets, Roche) and centrifuged (13,000 rpm,
4uC, 15 min) to remove cell debris. The amount of protein in the
supernatant was determined using the Bradford assay. Brain
membrane fractions or cell lysates of HEK293 cells were
incubated overnight at 4uC with protein A-Sepharose beads
(Sigma) and a specific antibody. Beads were pelleted by
centrifugation and washed three times with cold buffer (20 mM
Tris, 5 mM MgCl2, 0.2 mM EDTA, 20% glycerine, 300 mM
KCl; pH 7.9). The proteins were boiled for 5 min in Laemmli
sample buffer, separated by SDS-PAGE and transferred to PVDF
(Whatman). The western blot analysis was performed with rabbit
anti-HCN2 L [8], rabbit anti-cGKII (kindly provided by Peter
Ruth, Tu ¨bingen, Germany) or mouse anti-myc (clone 9E10, Cell
Signaling Technologies).
GFP-Trap assay
HEK293 cells were co-transfected with one of the C-terminal
HCN2 myc-tagged constructs together with the C-terminally
GFP-tagged cGKII construct (cGKII-GFP-pcDNA3). This com-
bination gave the most robust results in co-immunoprecipitation
experiments with C-terminal fragments of HCN2. While the anti-
cGKII antibody nicely pulled down complexes of full length
HCN2 and cGKII, it was less efficient in precipitating complexes
between cGKII and C-terminal fragments of HCN2. Cell lysis was
performed as described above. GFP-Trap-A (Chromotek) was
performed according to manufacturer’s instruction.
TiO2 pulldown
TiO2 Mag Sepharose beads (GE healthcare) were used
according to manufacturer’s instructions with adaptations.
500 mg cell lysates from HEK293 cells expressing cGKII and/
or myc-fusion proteins of wild type HCN2 (HCN2-CT) or HCN2-
S641A (HCN2-CT-S641A) C-terminus were incubated for 30 min
in binding buffer (1 M glycolic acid, 10 mM HEPES, pH 7.35,
3 mM 8-pCPT-cGMP (Calbiochem) and phosphatase inhibitors
(PhosSTOP, Roche). Subsequently, the beads were precipitated
using a magnetic rack and washed in 10 mM HEPES (pH 7.35)
than boiled for 5 min in Laemmli sample buffer, and proteins were
separated by SDS PAGE. The PVDF membrane was probed with
a mouse anti-myc antibody (clone 9E10, Cell Signaling Technol-
ogies).
Kinase assay
The procedure of the in vitro kinase assay was described
previously [39]. In COS-7 cells the cGKII is a soluble protein in
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For the kinase assay, COS-7 cells were transiently transfected
using the calcium phosphate method. The HCN2 wild-type
protein was compared to the HCN2 mutants HCN2-S641A and
HCN2-756STOP in the presence or absence of cGKII. To obtain
cell lysates, cells were washed twice with PBS and harvested. The
cells were suspended in hypoosmotic lysis buffer (10 mM K3PO4,
pH 7.4). Complete cell destruction was achieved by three times
passing through a 27-gauge syringe needle and an additional
freeze–thaw cycle. Lysates containing 30 mg of protein were
incubated in 50 mM 2-(N-morpholino)ethanesulfonnic acid (MES)
pH 6.9, 10 mM NaCl, 1 mM Mg
2+ acetate, 0.4 mM EGTA,
0.1% Triton X-100 and 3 mM 8-pCPT-cGMP (Calbiochem). The
reaction was started by adding 0.1 mM [c-
32P]-ATP (2,000 cpm/
pmol, PerkinElmer). After incubation for 15 s up to 10 min at
30uC, the reaction was stopped by addition of Laemmli buffer and
denaturation at 95uC for 5 min. Proteins were separated by SDS-
PAGE and blotted onto a PVDF membrane. Incorporated
radioactivity was visualized by autoradiography and phospho-
image analysis (BASReader 2.9, Raytest).
Electrophysiology
Currents of heterologously expressed HCN channels were
measured in HEK293 cells at room temperature 2–3 days after
transfection using the whole cell voltage-clamp technique. The
extracellular solution was composed of (in mM): 110 NaCl, 0.5
MgCl2, 1.8 CaCl2, 5 HEPES, 30 KCl, pH 7.4 adjusted with
NaOH. The intracellular solution contained (in mM): 130 KCl, 10
NaCl, 0.5 MgCl2, 1 EGTA, 5 HEPES, 3 Mg-ATP, 0.5 Na-GTP,
pH 7.4 adjusted with KOH. Pipettes were pulled from borosilicate
glass capillaries (GC150TF, Harvard Apparatus) and had
resistances of 2–3 MV when filled with the intracellular solution.
The cGMP-dependent kinase inhibitor KT5823 was purchased
from Cayman chemicals. A 1 mM stock solution was prepared in
ethyl acetate and was freshly diluted to a final concentration of
1 mM in extracellular solution before use.
Data were acquired at 10 kHz using an Axopatch 200B
amplifier and pClamp10.2 (Molecular Devises). Voltage clamp
data were analyzed off-line by using Clampfit 10.2 (Molecular
Devises). Steady-state activation curves were determined by
hyperpolarizing voltage steps from 2140 mV to 260 mV in
10 mV increments from a holding potential of 240 mV for 1.8 s
followed by a step to 2140 mV (Fig. 4A). Currents measured
immediately after the final step to 2140 mV, were normalized by
the maximal current (Imax) and plotted as a function of the
preceding membrane potential (Fig. 4A, indicated by a grey
arrow). The data points were fitted with the Boltzmann function:
(I2Imin)/(Imax2Imin)={12exp[(Vm2V0.5)/k]} where Imin is an
offset caused by a nonzero holding current, Vm is the test potential,
V0.5 is the membrane potential for half-maximal activation, and k
is the slope factor.
Statistics
All biochemical experiments were repeated at least three times
with protein samples obtained from three independent transfec-
tions or tissue preparations. For the quantification of the results
obtained in independent TiO2 pulldown assays, the intensity of
western blot bands was determined by counting the pixels per area
for HCN2-CT and HCN2-CT-S641A with or without cGKII,
respectively. The values were averaged and normalized to HCN2-
CT with or without cGKII, respectively. For electrophysiological
data, the statistical analysis was performed by one-way ANOVA.
Data are presented as mean 6 S.E.M. (n=number of recorded
cells). Values of p,0.01 were considered significant.
Acknowledgments
We thank Frank Bradke and Liane Meyn (Max Planck Institute for
Neurobiology) for the introduction into primary neuron culture. For the
cGKII antibody, thanks are given to Peter Ruth (Universita ¨t Tu ¨bingen).
We thank Pavel Osten (SUNY Downstate Brooklyn) for the syn1.1
promoter and Jennifer Schmidt for lentivirus preparation.
Author Contributions
Conceived and designed the experiments: VH SM XZ MB. Performed the
experiments: VH XZ. Analyzed the data: VH XZ SM MB. Contributed
reagents/materials/analysis tools: FH MB. Wrote the paper: VH SM MB.
References
1. Craven KB, Zagotta WN (2006) CNG and HCN channels: two peas, one pod.
Annu Rev Physiol 68: 375–401.
2. Wahl-Schott C, Biel M (2009) HCN channels: structure, cellular regulation and
physiological function. Cell Mol Life Sci 66: 470–494.
3. RobinsonRB,Siegelbaum SA(2003) Hyperpolarization-activatedcation currents:
from molecules to physiological function. Annu Rev Physiol 65: 453–480.
4. DiFrancesco D (2010) The role of the funny current in pacemaker activity. Circ
Res 106: 434–446.
5. Frere SG, Kuisle M, Luthi A (2004) Regulation of recombinant and native
hyperpolarization-activated cation channels. Mol Neurobiol 30: 279–305.
6. Nolan MF, Dudman JT, Dodson PD, Santoro B (2007) HCN1 channels control
resting and active integrative properties of stellate cells from layer II of the
entorhinal cortex. J Neurosci 27: 12440–12451.
7. Day M, Carr DB, Ulrich S, Ilijic E, Tkatch T, et al. (2005) Dendritic excitability
of mouse frontal cortex pyramidal neurons is shaped by the interaction among
HCN, Kir2, and Kleak channels. J Neurosci 25: 8776–8787.
8. Ludwig A, Budde T, Stieber J, Moosmang S, Wahl C, et al. (2003) Absence
epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2.
EMBO J 22: 216–224.
9. Magee JC (1998) Dendritic hyperpolarization-activated currents modify the
integrative properties of hippocampal CA1 pyramidal neurons. J Neurosci 18:
7613–7624.
10. Williams SR, Stuart GJ (2000) Site independence of EPSP time course is mediated
by dendritic I(h) in neocortical pyramidalneurons.J Neurophysiol 83:3177–3182.
11. Beaumont V, Zucker RS (2000) Enhancement of synaptic transmission by cyclic
AMP modulation of presynaptic Ih channels. Nat Neurosci 3: 133–141.
12. Poolos NP, Bullis JB, Roth MK (2006) Modulation of h-channels in
hippocampal pyramidal neurons by p38 mitogen-activated protein kinase.
J Neurosci 26: 7995–8003.
13. Chang F, Cohen IS, DiFrancesco D, Rosen MR, Tromba C (1991) Effects of
protein kinase inhibitors on canine Purkinje fibre pacemaker depolarization and
the pacemaker current i(f). J Physiol 440: 367–384.
14. Vargas G, Lucero MT (2002) Modulation by PKA of the hyperpolarization-
activated current (Ih) in cultured rat olfactory receptor neurons. J Membr Biol
188: 115–125.
15. Liao Z, Lockhead D, Larson ED, Proenza C (2010) Phosphorylation and
modulation of hyperpolarization-activated HCN4 channels by protein kinase A
in the mouse sinoatrial node. J Gen Physiol 136: 247–258.
16. Zong X, Eckert C, Yuan H, Wahl-Schott C, Abicht H, et al. (2005) A novel
mechanism of modulation of hyperpolarization-activated cyclic nucleotide-gated
channels by Src kinase. J Biol Chem 280: 34224–34232.
17. Moosmang S, Stieber J, Zong X, Biel M, Hofmann F, et al. (2001) Cellular
expression and functional characterization of four hyperpolarization-activated
pacemaker channels in cardiac and neuronal tissues. Eur J Biochem 268:
1646–1652.
18. Notomi T, Shigemoto R (2004) Immunohistochemical localization of Ih channel
subunits, HCN1-4, in the rat brain. J Comp Neurol 471: 241–276.
1 9 . W e r n e rC ,R a i v i c hG ,C o w e nM ,S t r e k a l o v aT ,S i l l a b e rI ,e ta l .( 2 0 0 4 )I m p o r t a n c eo f
NO/cGMP signalling via cGMP-dependent protein kinase II for controlling
emotionality and neurobehavioural effects of alcohol. Eur J Neurosci 20: 3498–3506.
20. Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M (1998) A family of
hyperpolarization-activated mammalian cation channels. Nature 393: 587–591.
21. Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, et al. (1999) Structure and
function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol
135: 105–149.
22. Zhou L, Siegelbaum SA (2007) Gating of HCN channels by cyclic nucleotides:
residue contacts that underlie ligand binding, selectivity, and efficacy. Structure
15: 655–670.
cGKII Inhibits HCN2 Activation
PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e1707823. Pape HC, Mager R (1992) Nitric oxide controls oscillatory activity in
thalamocortical neurons. Neuron 9: 441–448.
24. Musialek P, Lei M, Brown HF, Paterson DJ, Casadei B (1997) Nitric oxide can
increase heart rate by stimulating the hyperpolarization-activated inward
current, I(f). Circ Res 81: 60–68.
25. Taylor MK, Uhler MD (2000) The amino-terminal cyclic nucleotide binding site
of the type II cGMP-dependent protein kinase is essential for full cyclic
nucleotide-dependent activation. J Biol Chem 275: 28053–28062.
26. Zagotta WN, Olivier NB, Black KD, Young EC, Olson R, et al. (2003)
Structural basis for modulation and agonist specificity of HCN pacemaker
channels. Nature 425: 200–205.
27. Xu X, Vysotskaya ZV, Liu Q, Zhou L (2010) Structural basis for the cAMP-
dependent gating in human HCN4 channel. J Biol Chem, [Epub ahead of
print].
28. Moosmang S, Biel M, Hofmann F, Ludwig A (1999) Differential distribution of
four hyperpolarization-activated cation channels in mouse brain. Biol Chem
380: 975–980.
29. Serulle Y, Zhang S, Ninan I, Puzzo D, McCarthy M, et al. (2007) A GluR1-
cGKII interaction regulates AMPA receptor trafficking. Neuron 56: 670–688.
30. French PJ, Bijman J, Edixhoven M, Vaandrager AB, Scholte BJ, et al. (1995)
Isotype-specific activation of cystic fibrosis transmembrane conductance
regulator-chloride channels by cGMP-dependent protein kinase II. J Biol Chem
270: 26626–26631.
31. Golin-Bisello F, Bradbury N, Ameen N (2005) STa and cGMP stimulate CFTR
translocation to the surface of villus enterocytes in rat jejunum and is regulated
by protein kinase G. Am J Physiol Cell Physiol 289: C708–716.
32. Mistrik P, Mader R, Michalakis S, Weidinger M, Pfeifer A, et al. (2005) The
murine HCN3 gene encodes a hyperpolarization-activated cation channel with
slow kinetics and unique response to cyclic nucleotides. J Biol Chem 280:
27056–27061.
33. Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, et al. (2004)
Lentivirus-based genetic manipulations of cortical neurons and their optical and
electrophysiological monitoring in vivo. Proc Natl Acad Sci U S A 101:
18206–18211.
34. Uhler MD (1993) Cloning and expression of a novel cyclic GMP-dependent
protein kinase from mouse brain. J Biol Chem 268: 13586–13591.
35. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, et al. (1996) Intestinal
secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase
II. Science 274: 2082–2086.
36. de Hoop MJ, Meyn L, Dotti CG (1994) Culturing Hippocampal Neurons and
Astrocytes from Fetal Rodent Brain. In: Celis JE, ed. Cell biology : a laboratory
handbook. San Diego: Academic Press. pp 154–163.
37. Garvalov BK, Flynn KC, Neukirchen D, Meyn L, Teusch N, et al. (2007) Cdc42
regulates cofilin during the establishment of neuronal polarity. J Neurosci 27:
13117–13129.
38. Oster H, Werner C, Magnone MC, Mayser H, Feil R, et al. (2003) cGMP-
dependent protein kinase II modulates mPer1 and mPer2 gene induction and
influences phase shifts of the circadian clock. Curr Biol 13: 725–733.
39. Ammendola A, Geiselhoringer A, Hofmann F, Schlossmann J (2001) Molecular
determinants of the interaction between the inositol 1,4,5-trisphosphate
receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta.
J Biol Chem 276: 24153–24159.
40. Vaandrager AB, Ehlert EM, Jarchau T, Lohmann SM, de Jonge HR (1996) N-
terminal myristoylation is required for membrane localization of cGMP-
dependent protein kinase type II. J Biol Chem 271: 7025–7029.
cGKII Inhibits HCN2 Activation
PLoS ONE | www.plosone.org 10 February 2011 | Volume 6 | Issue 2 | e17078